Immune Checkpoint Inhibitors and Venous Thromboembolism: The More Things Change…
Thrombosis and Haemostasis · 01.11.2023 · 123 (11) · 1057-1059
DOI: 10.1055/a-2121-9679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.11.2023. Verfasst von Alok A Khorana. Beteiligte Einrichtung: Department of Hematology Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States. Hauptthemen laut MEDLINE: Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: NHLBI NIH HHS, Sondra and Stephen Hardis Chair in Oncology Research, National Heart, Lung, and Blood Institute.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States.
- Case Comprehensive Cancer Center, Cleveland, Ohio, United States.
ORCID-Profile: Alok A Khorana
Förderung
- NHLBI NIH HHS
- Sondra and Stephen Hardis Chair in Oncology Research
- National Heart, Lung, and Blood Institute
Zitieren
APA
Khorana, A. A. (2023). Immune Checkpoint Inhibitors and Venous Thromboembolism: The More Things Change…. Thrombosis and Haemostasis, 123(11), 1057-1059. https://doi.org/10.1055/a-2121-9679
Vancouver
Khorana AA. Immune Checkpoint Inhibitors and Venous Thromboembolism: The More Things Change…. Thrombosis and Haemostasis. 2023;123(11):1057-1059. doi:10.1055/a-2121-9679
BibTeX
@article{Khorana2023,
author = {Khorana, Alok A},
title = {Immune Checkpoint Inhibitors and Venous Thromboembolism: The More Things Change…},
journal = {Thrombosis and Haemostasis},
year = {2023},
volume = {123},
number = {11},
pages = {1057--1059},
doi = {10.1055/a-2121-9679}
}
EUVIMED